Independence Bank of Kentucky’s Edwards Lifesciences EW Stock Holding History

Independence Bank of Kentucky’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Hold	2,550	–	–	0.03%	272
2026 Q1	$204K	Hold	2,550	–	–	0.03%	280
2025 Q4	$217K	Hold	2,550	–	–	0.03%	278
2025 Q3	$198K	Hold	2,550	–	–	0.03%	285
2025 Q2	$199K	Hold	2,550	–	–	0.03%	283
2025 Q1	$185K	Hold	2,550	–	–	0.03%	279
2024 Q4	$189K	Buy	2,550 +960	+60%	+$67.2K	0.03%	286
2024 Q3	$105K	Buy	+1,590	New	+$116K	0.02%	323
2020 Q2	–	Sell	-171	Closed	-$11K	–	348
2020 Q1	$11K	Hold	171	–	–	0.01%	277
2019 Q4	$13K	Hold	171	–	–	0.01%	284
2019 Q3	$13K	Buy	+171	New	+$12K	0.01%	283
2018 Q2	–	Sell	-96	Closed	-$4K	–	326
2018 Q1	$4K	Buy	+96	New	+$4.17K	﹤0.01%	326

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Independence Bank of Kentucky's EW Position: Q2 2026 in Review

Independence Bank of Kentucky held its Edwards Lifesciences (EW) position steady in Q2 2026 at 2,550 shares worth $231K. The position accounts for 0.03% of the portfolio, ranked #272.

Independence Bank of Kentucky first reported a position in EW in Q1 2018 and has held it in 12 quarters since. 973 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Independence Bank of Kentucky held 2,550 shares of Edwards Lifesciences worth $231K as of Q2 2026.
Independence Bank of Kentucky left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.03% of Independence Bank of Kentucky's portfolio in Q2 2026, its #272 holding.
Independence Bank of Kentucky first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 12 quarters since.
973 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.